People respond differently to psychedelic drugs — genetics could be the reason

Psychedelic drugs have shown benefits as treatments for cluster headaches, anxiety and depression in clinical studies, but not for everyone. Now, in ACS Chemical Neuroscience, researchers report that one reason could be common genetic variations in one serotonin receptor.

RESEARCH NEWS TIP SHEET: STORY IDEAS FROM JOHNS HOPKINS

The June 4, 2020, issue of the weekly Johns Hopkins Medicine research newsletter on topics NOT related to COVID19. Stories this week: study shows pollutant may be more hazardous than previously thought; psilocybin tampers the brain’s ego center; and getting urban youth to wear bike helmets.